Advaita Capital

Neuralink is a biotechnology company focused on developing advanced brain-machine interfaces aimed at assisting individuals with paralysis and addressing neurological conditions. The company's technology is designed to provide high-bandwidth communication between the brain and external devices, facilitating both treatment and diagnosis of various brain diseases. Neuralink's innovations seek to not only restore lost functions but also enhance cognitive capabilities, potentially expanding the abilities of individuals and fostering a more inclusive community. Through its pioneering work, Neuralink aims to revolutionize the field of neuroscience and improve the quality of life for those affected by severe neurological disorders.

Proof of Impact B.V. is a company that operates a blockchain-based platform dedicated to verifying and financing impact projects. Founded in 2017 and based in Amsterdam, the Netherlands, it allows customers, including NGOs, corporations, non-profit organizations, and individuals, to direct their donations and investments towards projects with verified positive outcomes, such as child vaccinations and renewable energy initiatives. Additionally, the company offers a data intelligence platform designed to convert static environmental, social, and governance (ESG) data into actionable insights. This platform enables real-time measurement and reporting of impact data, making the process of investing in social and environmental initiatives more transparent and verifiable. By integrating innovative technological solutions, Proof of Impact aims to enhance business performance while promoting sustainability and social responsibility across various sectors.